Table 1.
Characteristics of Florida melanoma patients between 2001 and 2009 by marital status.
| Total N = 36,578 (100%) |
Marital status | P value | |||||
|---|---|---|---|---|---|---|---|
| Single N = 5,037 (13.8%) |
Married N = 25,438 (69.5%) |
Divorced N = 2,443 (6.7%) |
Widowed N = 3,660 (10.0%) |
||||
| Age at diagnosis∗ | Mean (SD) | 62.5 (16.2) | 51.0 (19.2) | 62.9 (14.5) | 59.0 (13.1) | 78.0 (9.9) | <0.001 |
|
| |||||||
| Sex | Male | 58.7 | 57.1 | 64.0 | 45.4 | 32.7 | <0.001 |
| Female | 41.3 | 42.9 | 36.0 | 54.6 | 67.3 | ||
|
| |||||||
| Insurance status | No insurance | 3.4 | 8.9 | 2.4 | 6.4 | 1.3 | <0.001 |
| Insurance | 96.6 | 91.1 | 97.6 | 93.6 | 98.7 | ||
|
| |||||||
| Race | White | 98.9 | 98.3 | 99.1 | 99.2 | 99.0 | <0.001 |
| Black | 0.6 | 0.8 | 0.5 | 0.5 | 0.8 | ||
| Other | 0.5 | 0.9 | 0.4 | 0.3 | 0.2 | ||
|
| |||||||
| Ethnicity | Non-Hispanic | 96.6 | 95.8 | 96.9 | 95.0 | 96.9 | <0.001 |
| Hispanic | 3.4 | 4.2 | 3.1 | 5.0 | 3.1 | ||
|
| |||||||
| Geographic area | Northwest | 4.9 | 4.8 | 4.9 | 5.8 | 3.9 | <0.001 |
| Northeast | 6.5 | 6.0 | 6.6 | 7.2 | 5.5 | ||
| North central | 3.6 | 3.8 | 3.6 | 4.6 | 3.1 | ||
| Central west | 20.9 | 22.7 | 20.5 | 20.1 | 21.8 | ||
| Central | 18 | 15.0 | 19.3 | 15.5 | 14.7 | ||
| Central east | 10 | 8.6 | 10.0 | 11.0 | 11.1 | ||
| Southeast | 27.7 | 32.4 | 26.0 | 29.5 | 31.8 | ||
| Southwest | 8.5 | 6.7 | 9.2 | 6.3 | 8.2 | ||
|
| |||||||
| Tobacco use | Never | 61.8 | 63.3 | 61.9 | 54.6 | 63.6 | <0.001 |
| Current | 13.6 | 21.2 | 11.8 | 22.9 | 9.3 | ||
| Former | 24.6 | 15.5 | 26.3 | 22.5 | 27.1 | ||
|
| |||||||
| Histology | Acral lentiginous | 0.8 | 0.8 | 0.7 | 0.9 | 1.1 | <0.001 |
| Lentigo maligna | 6.5 | 4.1 | 6.6 | 5.6 | 9.3 | ||
| Superficial spreading | 12.1 | 13.6 | 12.3 | 12.0 | 9.2 | ||
| Nodular melanoma | 5.3 | 6.9 | 4.9 | 5.7 | 6.0 | ||
| Other | 75.3 | 74.6 | 75.6 | 75.7 | 74.4 | ||
|
| |||||||
| Staging | Early | 88.5 | 84.3 | 89.9 | 85.0 | 86.0 | <0.001 |
| Late | 11.5 | 15.7 | 10.1 | 15.0 | 14.0 | ||
|
| |||||||
| Primary site | Face | 15.0 | 11.7 | 15.0 | 12.0 | 21.2 | <0.001 |
| External ear | 3.1 | 2.5 | 3.3 | 2.3 | 3.3 | ||
| Scalp and neck | 7.9 | 7.5 | 8.3 | 5.8 | 6.9 | ||
| Trunk | 31.5 | 35.2 | 32.0 | 33.2 | 21.7 | ||
| Upper limb and shoulder | 25.9 | 24.8 | 25.8 | 27.6 | 27.0 | ||
| Lower limb and hip | 16.7 | 18.4 | 15.6 | 19.2 | 19.9 | ||
SD = standard deviation; results are presented as % using the survey design unless otherwise specified. ∗ANOVA; all others, chi-square test. The races grouped under “others” consist of Micronesian, Chamorro/Chamoru, American Indian, Aleutia, Alaskan Native or Eskimo (includes all indigenous populations of the Western hemisphere), Chinese, Polynesian, Japanese, Tahitian, Filipino, Samoan, Hawaiian, Tongan, Korean, Melanesian, Vietnamese, New Guinean, Laotian, other Asian, including Asian, not otherwise specified, Hmong, Pacific Islander, Kampuchean, Thai, Asian Indian or Pakistani, Asian Indian, Pakistani, Guamanian, Fiji Islanders, and Oriental, not otherwise specified, as well as unknown races. The histological categories grouped under “others” consist of Malignant Melanoma NOS, Balloon Cell Melanoma, Regressing Melanoma, Meningeal Melanomatosis, Amelanotic Melanoma, Melan Junction Nevus, Melan in Precanc Melanoma, Desmoplastic Melanoma, Mucosal Lentiginous Melan, Melan Giant Pig Nevus, Epithelioid/Spindle Cell Melan, Epithel Cell Melanoma, Spindle Cell Melanoma NOS, Spindle Cell Melanoma type A, Spindle Cell Melanoma type B, and Blue Nevus Malignant.